substance p has been researched along with Behavior Disorders in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (54.55) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuoka, Y; Hatakeyama, A; Hatakeyama, R; Sasaki, H; Sato, A | 1 |
| Jonas, C | 1 |
| Taban, CH | 1 |
| Ballenger, JC; Bunney, WE; Gold, P; Goodwin, FK; Post, RM; Rubinow, DR | 1 |
| Shibuya, H | 1 |
| Houvenagel, E | 1 |
| Stahl, SM | 1 |
| Wetterberg, L | 1 |
| Malek-Ahmadi, P | 1 |
| Kaiya, H; Morikiyo, M; Ofuji, M; Takeuchi, K; Uematsu, M | 1 |
| Gillin, CJ; Govoni, S; Hong, J; Iadarola, M; Kleinman, JE | 1 |
6 review(s) available for substance p and Behavior Disorders
| Article | Year |
|---|---|
Peptides in the cerebrospinal fluid of neuropsychiatric patients: an approach to central nervous system peptide function.
Topics: Adrenocorticotropic Hormone; Angiotensins; beta-Endorphin; Calcitonin; Endorphins; Humans; Mental Disorders; Nervous System Diseases; Oxytocin; Peptides; Somatostatin; Substance P; Vasoactive Intestinal Peptide; Vasopressins; Vasotocin | 1982 |
[Neuropeptides and mental disorders].
Topics: Aged; Alzheimer Disease; Animals; Brain; Cholecystokinin; Depressive Disorder; Endorphins; Female; Humans; Male; Mental Disorders; Middle Aged; Nerve Tissue Proteins; Neurotransmitter Agents; Schizophrenia; Substance P; Vasopressins | 1983 |
[Fibromyalgia: pathogenic concepts].
Topics: Enkephalins; Fibromyalgia; Humans; Hypothyroidism; Mental Disorders; Neurotransmitter Agents; Pain Measurement; Serotonin; Sleep Wake Disorders; Substance P | 1993 |
[Developing lines in psychoendocrinology].
Topics: Adrenocorticotropic Hormone; Animals; Cortisone; Electroconvulsive Therapy; Endocrine System Diseases; Hormones; Humans; Learning; Memory; Mental Disorders; MSH Release-Inhibiting Hormone; Nerve Tissue Proteins; Peptides; Psychoses, Substance-Induced; Psychotropic Drugs; Schizophrenia; Somatomedins; Somatostatin; Steroids; Substance P; Thyrotropin; Vasopressins | 1977 |
Substance P and neuropsychiatric disorders: an overview.
Topics: Humans; Mental Disorders; Nervous System Diseases; Substance P | 1992 |
Substance P involved in mental disorders.
Topics: Animals; Antipsychotic Agents; Brain; Humans; Mental Disorders; Schizophrenia; Substance P | 1988 |
5 other study(ies) available for substance p and Behavior Disorders
| Article | Year |
|---|---|
[Therapy for geriatric syndrome].
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Mental Disorders; Nutritional Support; Pneumonia, Aspiration; Prognosis; Quality of Life; Substance P; Syndrome | 2006 |
[Fibromyalgia: rheumatologic or psychiatric disease?].
Topics: Adult; Anxiety Disorders; Child; Diagnosis, Differential; Fibromyalgia; Genetic Predisposition to Disease; Humans; Mental Disorders; Prevalence; Risk Factors; Somatoform Disorders; Stress Disorders, Post-Traumatic; Substance P | 2006 |
[Neuropeptides and psychiatry report presented at the French-Swiss Psychiatric meeting in Bel-Air, Geneva, 4 May 1980].
Topics: Animals; Behavior; Brain; Endorphins; Humans; Mental Disorders; Neurons; Neurotransmitter Agents; Psychotic Disorders; Receptors, Neurotransmitter; Substance P | 1981 |
Peptides and psychiatry, Part 3: substance P and serendipity: novel psychotropics are a possibility.
Topics: Antidepressive Agents; Drug Design; Forecasting; Humans; Mental Disorders; Psychopharmacology; Psychotropic Drugs; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Receptors, Neurokinin-3; Substance P; Tachykinins | 1999 |
Neuropeptides in human brain--postmortem studies.
Topics: Adult; Aged; Alcoholism; Brain Chemistry; Cholecystokinin; Enkephalin, Methionine; Heroin Dependence; Humans; Mental Disorders; Middle Aged; Nerve Tissue Proteins; Neurotensin; Psychotic Disorders; Schizophrenia; Substance P; Suicide | 1985 |